Patterson Companies, Inc. (Nasdaq:PDCO) today reported consolidated net sales of approximately $1.4 billion (see attached Sales Summary for further details) in its fiscal third quarter ended January 26, 2019, an increase of 1.6 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and changes in product selling relationships, increased 2.5 percent.
Reported net income attributable to Patterson Companies, Inc. for the third quarter of fiscal year 2019 was $31.2 million, or $0.33 per diluted share, compared to $109.0 million, or $1.18 per diluted share, in last year’s fiscal third quarter. The prior year period included the recognition of a provisional tax benefit of $77.3 million, reflecting the revaluation of tax-deferred assets and liabilities, net of a one-time transition tax on unremitted foreign earnings as a result of the Tax Cuts and Jobs Act (“2017 Tax Act”) enacted during the prior year period. Adjusted net income1 attributable to Patterson Companies, Inc., which excludes deal amortization costs, integration and business restructuring costs and discrete tax matters, totaled $35.6 million for the third quarter of fiscal 2019, or $0.38 per diluted share, compared to $39.6 million in the same quarter last year, or $0.43 per diluted share.
“We are pleased with our performance during the third quarter. We delivered the third consecutive quarter of year-over-year revenue growth as well as continued, sequential operating margin improvement,” said Mark Walchirk, President and CEO of Patterson Companies. “We continued to execute against our strategic priorities, which resulted in Dental segment revenue growth and solid performance in our Animal Health segment. Our progress throughout fiscal 2019 provides us with confidence that we are taking the right steps to build a stronger Patterson that is well positioned to deliver long-term value.”
Patterson Animal Health
Reported net sales in our Animal Health segment for the third quarter of fiscal 2019, which comprised approximately 58 percent of the company’s total sales, were $807.5 million compared to $794.9 million in the same quarter last year. Internal sales for the segment increased 2.8 percent from the fiscal 2018 third quarter.
Patterson Dental
Reported net sales in our Dental segment for the third quarter of fiscal 2019, which represented approximately 42 percent of total company sales, were $579.7 million compared to $577.9 million in the same quarter last year. Internal sales increased 0.9 percent compared to the fiscal 2018 third quarter.
Balance Sheet and Capital Allocation
For the first nine months of fiscal 2019, Patterson Companies generated $76.3 million of cash from operating activities and collected deferred purchase price receivables of $308.6 million for a total of $384.9 million, compared to a total of $77.1 million in the same period last year. During the first nine months of fiscal 2019, debt has been reduced by $231.0 million and cash has grown by $54.4 million.
In the third quarter of fiscal 2019, Patterson Companies paid $24.8 million in cash dividends to shareholders. On a year-to-date basis, Patterson has returned $74.7 million in cash dividends to shareholders.
Year-to-Date Results
Consolidated net sales for the first nine months of fiscal 2019 totaled $4.1 billion, a 1.8 percent year-over-year increase. Reported net income attributable to Patterson Companies, Inc. was $55.6 million, or $0.60 per diluted share, compared to $180.0 million, or $1.93 per diluted share in last year's period. The prior year period included the recognition of a provisional tax benefit of $77.3 million, reflecting the revaluation of tax-deferred assets and liabilities, net of a one-time transition tax on unremitted foreign earnings as a result of the 2017 Tax Act. In July 2018, Patterson Companies booked a pre-tax reserve of $28.3 million for the anticipated settlement of purported class action antitrust litigation.
Adjusted net income1 attributable to Patterson Companies, Inc., which excludes deal amortization costs, integration and business restructuring costs, legal reserve costs and discrete tax matters, totaled $95.9 million, or $1.03 per diluted share, compared to adjusted net income of $128.6 million, or $1.38 per diluted share, in the year-ago period.
FY2019 Guidance
Patterson Companies today narrowed its fiscal 2019 earnings guidance, which is provided on both a GAAP and non-GAAP adjusted1 basis:
Our guidance is for current operations as well as completed or previously announced acquisitions and does not include the impact of potential future acquisitions or similar transactions, if any, or impairments and material restructurings beyond those previously publicly disclosed. Our guidance assumes North American and international market conditions similar to those experienced in fiscal 2018.
1Non-GAAP Financial Measures
The Reconciliation of GAAP to non-GAAP Measures table appearing behind the accompanying financial information is provided to adjust reported GAAP measures, namely operating income, income before taxes, income tax expense, net income, net income attributable to Patterson Companies, Inc. and diluted earnings per share attributable to Patterson Companies, Inc., for the impact of deal amortization, integration and business restructuring expenses, legal reserve costs and discrete tax matters, along with the related tax effects of these items.
Management believes that these non-GAAP measures may provide a helpful representation of the company's third-quarter performance and earnings guidance, and enable comparison of financial results between periods where certain items may vary independent of business performance. These non-GAAP financial measures are presented solely for informational and comparative purposes and should not be regarded as a replacement for corresponding, similarly captioned, GAAP measures.
In addition, the term “internal sales” used in this release represents net sales adjusted to exclude foreign currency impact and changes in product selling relationships. Foreign currency impact represents the difference in results that is attributable to fluctuations in currency exchange rates the company uses to convert results for all foreign entities where the functional currency is not the U.S. dollar. The company calculates the impact as the difference between the current period results translated using the current period currency exchange rates and using the comparable prior period's currency exchange rates. The company believes the disclosure of net sales changes in constant currency provides useful supplementary information to investors in light of significant fluctuations in currency rates.
Third-Quarter Conference Call and Replay
Patterson Companies’ fiscal 2019 third-quarter earnings conference call will start at 10 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. The conference call will be archived on the Patterson Companies website. A replay of the fiscal 2019 third-quarter conference call can be heard for one week at 800-585-8367 and by providing the Conference ID 1978448 when prompted.
About Patterson Companies Inc.
Patterson Companies Inc. (Nasdaq: PDCO) is a value-added distributor serving the dental and animal health markets.
Dental Market
Patterson’s Dental segment provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.
Animal Health Market
Patterson’s Animal Health segment is a leading distributor of products, services and technologies to both the production and companion animal health markets in North America and the U.K.
This press release contains certain forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond Patterson's ability to control. Forward-looking statements generally can be identified by words such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. It is uncertain whether any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what impact they will have on the results of operations and financial condition of Patterson or the price of Patterson stock. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those indicated in such forward-looking statements. Such risks and uncertainties include, without limitation, operations disruptions attributable to our enterprise resource planning system implementation; our ability to attract or retain qualified sales representatives and service technicians who relate directly with our customers; the reduction, modification, cancellation or delay of purchases of innovative, high-margin equipment; material changes in our purchasing relationships with suppliers; changes in general market and economic conditions; and the other risks and important factors contained and identified in Patterson's filings with the Securities and Exchange Commission, such as its Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K, any of which could cause actual results to differ materially from the forward-looking statements. Any forward-looking statement in this press release speaks only as of the date on which it is made. Except to the extent required under the federal securities laws, Patterson does not intend to update or revise the forward-looking statements.
| PATTERSON COMPANIES, INC. | ||||||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||
| (In thousands, except per share amounts) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||
| January 26, | January 27, | January 26, | January 27, | |||||||||||||
| 2019 | 2018 | 2019 | 2018 | |||||||||||||
| Net sales | $ | 1,396,745 | $ | 1,375,222 | $ | 4,137,817 | $ | 4,065,074 | ||||||||
| Gross profit | 299,509 | 294,736 | 878,248 | 909,527 | ||||||||||||
| Operating expenses | 254,146 | 244,690 | 787,155 | 730,889 | ||||||||||||
| Operating income | 45,363 | 50,046 | 91,093 | 178,638 | ||||||||||||
| Other income (expense): | ||||||||||||||||
| Other income, net | 1,427 | 2,096 | 8,621 | 4,768 | ||||||||||||
| Interest expense | (9,172 | ) | (11,783 | ) | (29,849 | ) | (34,454 | ) | ||||||||
| Income before taxes | 37,618 | 40,359 | 69,865 | 148,952 | ||||||||||||
| Income tax expense (benefit) | 6,564 | (68,596 | ) | 14,674 | (31,094 | ) | ||||||||||
| Net income | 31,054 | 108,955 | 55,191 | 180,046 | ||||||||||||
| Net loss attributable to noncontrolling interests | (171 | ) | — | (447 | ) | — | ||||||||||
| Net income attributable to Patterson Companies, Inc. | $ | 31,225 | $ | 108,955 | $ | 55,638 | $ | 180,046 | ||||||||
| Earnings per share attributable to Patterson Companies, Inc.: | ||||||||||||||||
| Basic | $ | 0.34 | $ | 1.18 | $ | 0.60 | $ | 1.94 | ||||||||
| Diluted | $ | 0.33 | $ | 1.18 | $ | 0.60 | $ | 1.93 | ||||||||
| Weighted average shares: | ||||||||||||||||
| Basic | 92,818 | 91,949 | 92,677 | 92,674 | ||||||||||||
| Diluted | 93,653 | 92,609 | 93,347 | 93,323 | ||||||||||||
| Dividends declared per common share | $ | 0.26 | $ | 0.26 | $ | 0.78 | $ | 0.78 | ||||||||
| PATTERSON COMPANIES, INC. | |||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
| (In thousands) | |||||||
| (Unaudited) | |||||||
| January 26, | April 28, | ||||||
| 2019 | 2018 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 117,431 | $ | 62,984 | |||
| Receivables, net | 547,180 | 826,877 | |||||
| Inventory | 845,846 | 779,834 | |||||
| Prepaid expenses and other current assets | 169,209 | 103,029 | |||||
| Total current assets | 1,679,666 | 1,772,724 | |||||
| Property and equipment, net | 290,271 | 290,590 | |||||
| Goodwill and identifiable intangibles, net | 1,174,475 | 1,205,401 | |||||
| Long-term receivables, net and other | 176,113 | 202,949 | |||||
| Total assets | $ | 3,320,525 | $ | 3,471,664 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 688,125 | $ | 610,368 | |||
| Other accrued liabilities | 193,442 | 205,415 | |||||
| Current maturities of long-term debt | 22,131 | 76,598 | |||||
| Borrowings on revolving credit | 29,000 | 16,000 | |||||
| Total current liabilities | 932,698 | 908,381 | |||||
| Long-term debt | 732,640 | 922,030 | |||||
| Other non-current liabilities | 182,490 | 179,463 | |||||
| Total liabilities | 1,847,828 | 2,009,874 | |||||
| Stockholders' equity | 1,472,697 | 1,461,790 | |||||
| Total liabilities and stockholders' equity | $ | 3,320,525 | $ | 3,471,664 | |||
| PATTERSON COMPANIES, INC. | ||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| (In thousands) | ||||||||
| (Unaudited) | ||||||||
| Nine Months Ended | ||||||||
| January 26, | January 27, | |||||||
| 2019 | 2018 | |||||||
| Operating activities: | ||||||||
| Net income | $ | 55,191 | $ | 180,046 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 62,425 | 62,787 | ||||||
| Non-cash employee compensation | 22,282 | 22,999 | ||||||
| Deferred consideration in securitized receivables | (308,592 | ) | (37,068 | ) | ||||
| Change in assets and liabilities, net of acquired | 245,038 | (188,751 | ) | |||||
| Net cash provided by operating activities | 76,344 | 40,013 | ||||||
| Investing activities: | ||||||||
| Additions to property and equipment | (33,926 | ) | (28,239 | ) | ||||
| Collection of deferred purchase price receivables | 308,592 | 37,068 | ||||||
| Other investing activities | 2,875 | 10,600 | ||||||
| Net cash provided by investing activities | 277,541 | 19,429 | ||||||
| Financing activities: | ||||||||
| Dividends paid | (74,731 | ) | (74,641 | ) | ||||
| Repurchases of common stock | — | (87,500 | ) | |||||
| Retirement of long-term debt | (244,010 | ) | (7,377 | ) | ||||
| Draw on revolving credit | 13,000 | 120,000 | ||||||
| Other financing activities | 6,228 | 7,546 | ||||||
| Net cash used in financing activities | (299,513 | ) | (41,972 | ) | ||||
| Effect of exchange rate changes on cash | 75 | 5,576 | ||||||
| Net change in cash and cash equivalents | 54,447 | 23,046 | ||||||
| Cash and cash equivalents at beginning of period | 62,984 | 94,959 | ||||||
| Cash and cash equivalents at end of period | $ | 117,431 | $ | 118,005 | ||||
| PATTERSON COMPANIES, INC. | ||||||||||||||||
| SALES SUMMARY | ||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
|
January 26, |
January 27, |
Total |
Foreign |
Other (a) |
Internal |
|||||||||||
|
Three Months Ended |
||||||||||||||||
| Consolidated net sales | ||||||||||||||||
| Consumable | $ | 1,079,566 | $ | 1,074,189 | 0.5% | (1.0)% | (0.1)% | 1.6% | ||||||||
| Equipment and software | 234,251 | 222,574 | 5.2 | (0.5) | — | 5.7 | ||||||||||
| Other | 82,928 | 78,459 | 5.7 | (0.6) | — | 6.3 | ||||||||||
| Total | $ | 1,396,745 | $ | 1,375,222 | 1.6% | (0.9)% | —% | 2.5% | ||||||||
| Dental | ||||||||||||||||
| Consumable | $ | 294,708 | $ | 302,296 | (2.5)% | (0.6)% | —% | (1.9)% | ||||||||
| Equipment and software | 217,649 | 207,000 | 5.1 | (0.5) | — | 5.6 | ||||||||||
| Other | 67,376 | 68,581 | (1.8) | (0.5) | — | (1.3) | ||||||||||
| Total | $ | 579,733 | $ | 577,877 | 0.3% | (0.6)% | —% | 0.9% | ||||||||
| Animal Health | ||||||||||||||||
| Consumable | $ | 784,858 | $ | 771,893 | 1.7% | (1.1)% | (0.1)% | 2.9% | ||||||||
| Equipment and software | 16,602 | 15,574 | 6.6 | — | — | 6.6 | ||||||||||
| Other | 6,035 | 7,400 | (18.4) | (1.8) | — | (16.6) | ||||||||||
| Total | $ | 807,495 | $ | 794,867 | 1.6% | (1.1)% | (0.1)% | 2.8% | ||||||||
| Corporate | ||||||||||||||||
| Other | $ | 9,517 | $ | 2,478 | 284.1% | —% | —% | 284.1% | ||||||||
| Total | $ | 9,517 | $ | 2,478 | 284.1% | —% | —% | 284.1% | ||||||||
| (a) Sales of certain products previously recognized on a gross basis were recognized on a net basis during the three and nine months ended January 26, 2019. |
| PATTERSON COMPANIES, INC. | ||||||||||||||||
| SALES SUMMARY | ||||||||||||||||
| (Dollars in thousands) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
|
January 26, |
January 27, |
Total |
Foreign |
Other (a) |
Internal |
|||||||||||
|
Nine Months Ended |
||||||||||||||||
| Consolidated net sales | ||||||||||||||||
| Consumable | $ | 3,327,214 | $ | 3,270,385 | 1.7% | (0.2)% | (0.2)% | 2.1% | ||||||||
| Equipment and software | 563,269 | 540,860 | 4.1 | (0.2) | — | 4.3 | ||||||||||
| Other | 247,334 | 253,829 | (2.6) | (0.1) | — | (2.5) | ||||||||||
| Total | $ | 4,137,817 | $ | 4,065,074 | 1.8% | (0.2)% | (0.1)% | 2.1% | ||||||||
| Dental | ||||||||||||||||
| Consumable | $ | 902,753 | $ | 933,691 | (3.3)% | (0.1)% | —% | (3.2)% | ||||||||
| Equipment and software | 520,292 | 504,376 | 3.2 | (0.2) | — | 3.4 | ||||||||||
| Other | 205,268 | 212,247 | (3.3) | (0.1) | — | (3.2) | ||||||||||
| Total | $ | 1,628,313 | $ | 1,650,314 | (1.3)% | (0.2)% | —% | (1.1)% | ||||||||
| Animal Health | ||||||||||||||||
| Consumable | $ | 2,424,461 | $ | 2,336,694 | 3.8% | (0.3)% | (0.2)% | 4.3% | ||||||||
| Equipment and software | 42,977 | 36,484 | 17.8 | — | — | 17.8 | ||||||||||
| Other | 20,679 | 21,408 | (3.4) | (0.2) | — | (3.2) | ||||||||||
| Total | $ | 2,488,117 | $ | 2,394,586 | 3.9% | (0.3)% | (0.2)% | 4.4% | ||||||||
| Corporate | ||||||||||||||||
| Other | $ | 21,387 | $ | 20,174 | 6.0% | —% | —% | 6.0% | ||||||||
| Total | $ | 21,387 | $ | 20,174 | 6.0% | —% | —% | 6.0% | ||||||||
| (a) Sales of certain products previously recognized on a gross basis were recognized on a net basis during the three and nine months ended January 26, 2019. |
| PATTERSON COMPANIES, INC. | ||||||||||||||||
| OPERATING INCOME BY SEGMENT | ||||||||||||||||
| (In thousands) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||
|
January 26, |
January 27, |
January 26, |
January 27, |
|||||||||||||
| Operating income (loss) | ||||||||||||||||
| Dental | $ | 51,120 | $ | 58,439 | $ | 128,587 | $ | 183,165 | ||||||||
| Animal Health | 15,033 | 18,037 | 56,096 | 57,930 | ||||||||||||
| Corporate | (20,790 | ) | (26,430 | ) | (93,590 | ) | (62,457 | ) | ||||||||
| Total | $ | 45,363 | $ | 50,046 | $ | 91,093 | $ | 178,638 | ||||||||
| PATTERSON COMPANIES, INC. | ||||||||||||||||||||||
|
RECONCILIATION OF GAAP TO NON-GAAP MEASURES |
||||||||||||||||||||||
| (Dollars in thousands, except per share amounts) | ||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||
| For the three months ended January 26, 2019 | GAAP | Deal amortization |
Integration and |
Legal reserve | Discrete tax matters | Non-GAAP | ||||||||||||||||
| Operating income | $ | 45,363 | $ | 9,274 | $ | - |
$ |
- |
$ |
- | $ | 54,637 | ||||||||||
| Other expense, net | (7,745 | ) | - | - | - | - | (7,745 | ) | ||||||||||||||
| Income before taxes | 37,618 | 9,274 | - | - | - | 46,892 | ||||||||||||||||
| Income tax expense (benefit) | 6,564 | 2,219 | - | - | 2,686 | 11,469 | ||||||||||||||||
| Net income | 31,054 | 7,055 | - | - | (2,686 | ) | 35,423 | |||||||||||||||
| Net loss attributable to noncontrolling interests | (171 | ) | - | - | - | - | (171 | ) | ||||||||||||||
| Net income attributable to Patterson Companies, Inc. | $ | 31,225 | $ | 7,055 | $ | - | $ | - | $ | (2,686 | ) | $ | 35,594 | |||||||||
| Diluted earnings per share attributable to Patterson Companies, Inc.* | $ | 0.33 | $ | 0.08 | $ | - | $ | - | $ | (0.03 | ) | $ | 0.38 | |||||||||
| Operating income as a % of sales | 3.2 | % | 3.9 | % | ||||||||||||||||||
| Effective tax rate | 17.4 | % | 24.5 | % | ||||||||||||||||||
| For the three months ended January 27, 2018 | GAAP | Deal amortization |
Integration and |
Legal reserve | Discrete tax matters | Non-GAAP | ||||||||||||||||
| Operating income | $ | 50,046 | $ | 9,692 | $ | - | $ | - | $ | - | $ | 59,738 | ||||||||||
| Other expense, net | (9,687 | ) | - | - | - | - | (9,687 | ) | ||||||||||||||
| Income before taxes | 40,359 | 9,692 | - | - | - | 50,051 | ||||||||||||||||
| Income tax expense (benefit) | (68,596 | ) | 2,209 | (370 | ) | - | 77,256 | 10,499 | ||||||||||||||
| Net income | 108,955 | 7,483 | 370 | - | (77,256 | ) | 39,552 | |||||||||||||||
| Net loss attributable to noncontrolling interests | - | - | - | - | - | - | ||||||||||||||||
| Net income attributable to Patterson Companies, Inc. | $ | 108,955 | $ | 7,483 | $ | 370 | $ | - | $ | (77,256.00 | ) | $ | 39,552 | |||||||||
| Diluted earnings per share attributable to Patterson Companies, Inc.* | $ | 1.18 | $ | 0.08 | $ | - | $ | - | $ | (0.83 | ) | $ | 0.43 | |||||||||
| Operating income as a % of sales | 3.6 | % | 4.3 | % | ||||||||||||||||||
| Effective tax rate | (170.0 | )% | 21.0 | % | ||||||||||||||||||
| For the nine months ended January 26, 2019 | GAAP | Deal amortization |
Integration and |
Legal reserve | Discrete tax matters | Non-GAAP | ||||||||||||||||
| Operating income | $ | 91,093 | $ | 28,955 | $ | - |
$ |
28,263 |
$ |
- | $ | 148,311 | ||||||||||
| Other expense, net | (21,228 | ) | - | - | - | - | (21,228 | ) | ||||||||||||||
| Income before taxes | 69,865 | 28,955 | - | 28,263 | - | 127,083 | ||||||||||||||||
| Income tax expense (benefit) | 14,674 | 6,794 | - | 7,523 | 2,686 | 31,677 | ||||||||||||||||
| Net income | 55,191 | 22,161 | - | 20,740 | (2,686 | ) | 95,406 | |||||||||||||||
| Net loss attributable to noncontrolling interests | (447 | ) | - | - | - | - | (447 | ) | ||||||||||||||
| Net income attributable to Patterson Companies, Inc. | $ | 55,638 | $ | 22,161 | $ | - | $ | 20,740 | $ | (2,686 | ) | $ | 95,853 | |||||||||
| Diluted earnings per share attributable to Patterson Companies, Inc.* | $ | 0.60 | $ | 0.24 | $ | - | $ | 0.22 | $ | (0.03 | ) | $ | 1.03 | |||||||||
| Operating income as a % of sales | 2.2 | % | 3.6 | % | ||||||||||||||||||
| Effective tax rate | 21.0 | % | 24.9 | % | ||||||||||||||||||
| For the nine months ended January 27, 2018 | GAAP | Deal amortization |
Integration and |
Legal reserve | Discrete tax matters | Non-GAAP | ||||||||||||||||
| Operating income | $ | 178,638 | $ | 28,982 | $ | 8,594 | $ | - | $ | - | $ | 216,214 | ||||||||||
| Other expense, net | (29,686 | ) | - | - | - | - | (29,686 | ) | ||||||||||||||
| Income before taxes | 148,952 | 28,982 | 8,594 | - | - | 186,528 | ||||||||||||||||
| Income tax expense (benefit) | (31,094 | ) | 8,900 | 2,879 | - | 77,256 | 57,941 | |||||||||||||||
| Net income | 180,046 | 20,082 | 5,715 | - | (77,256 | ) | 128,587 | |||||||||||||||
| Net loss attributable to noncontrolling interests | - | - | - | - | - | - | ||||||||||||||||
| Net income attributable to Patterson Companies, Inc. | $ | 180,046 | $ | 20,082 | $ | 5,715 | $ | - | $ | (77,256 | ) | $ | 128,587 | |||||||||
| Diluted earnings per share attributable to Patterson Companies, Inc.* | $ | 1.93 | $ | 0.22 | $ | 0.06 | $ | - | $ | (0.83 | ) | $ | 1.38 | |||||||||
| Operating income as a % of sales | 4.4 | % | 5.3 | % | ||||||||||||||||||
| Effective tax rate | (20.9 | )% | 31.1 | % | ||||||||||||||||||
| * May not sum due to rounding | ||||||||||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20190228005195/en/
John M. Wright, Investor Relations
Patterson Companies
Inc.
john.wright@pattersoncompanies.com
pattersoncompanies.com